Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youcef Mehellou

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|March 22, 2019
Sequence specific assignment and determination of OSR1 C-terminal domain structure by NMRMubarak A AlAmri, Mark Jeeves, Youcef Mehellou
ACS Medicinal Chemistry Letters|January 19, 2019
The ProTide Prodrug Technology: Where Next?Ashwag S Alanazi, Edward James, Youcef Mehellou
Medchemcomm|March 19, 2019
Phosphotyrosine prodrugs: design, synthesis and anti-STAT3 activity of ISS-610 aryloxy triester phosphoramidate prodrugsAgeo Miccoli, Binar A Dhiani, Youcef Mehellou
Journal of Medicinal Chemistry|November 4, 2021
Aryloxy Pivaloyloxymethyl Prodrugs as Nucleoside Monophosphate ProdrugsAshwag S Alanazi, Ageo Miccoli, Youcef Mehellou
Chemmedchem|April 1, 2018
Niclosamide, a Drug with Many (Re)purposesHachemi Kadri, Olivia A Lambourne, Youcef Mehellou
Journal of Medicinal Chemistry|August 10, 2017
The ProTide Prodrug Technology: From the Concept to the ClinicYoucef Mehellou, Hardeep S Rattan, Jan Balzarini
Bioorganic & Medicinal Chemistry Letters|May 9, 2007
Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Christopher McGuigan, Andrea Brancale, et al.
Biochemical and Biophysical Research Communications|August 24, 2020
SPAK and OSR1 kinases bind and phosphorylate the β<sub>2</sub>-Adrenergic receptorAbdulrahman Elzwawi, Gillian Grafton, Nicholas M Barnes, et al.
Journal of Medicinal Chemistry|August 26, 2016
Nucleoside Phosphate and Phosphonate Prodrug Clinical CandidatesPeter J Thornton, Hachemi Kadri, Ageo Miccoli, et al.
Biochemical and Biophysical Research Communications|August 1, 2018
C-terminal phosphorylation of SPAK and OSR1 kinases promotes their binding and activation by the scaffolding protein MO25Youcef Mehellou, Mubarak A Alamri, Binar A Dhiani, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|March 22, 2019
Sequence specific assignment and determination of OSR1 C-terminal domain structure by NMRMubarak A AlAmri, Mark Jeeves, Youcef Mehellou
ACS Medicinal Chemistry Letters|January 19, 2019
The ProTide Prodrug Technology: Where Next?Ashwag S Alanazi, Edward James, Youcef Mehellou
Medchemcomm|March 19, 2019
Phosphotyrosine prodrugs: design, synthesis and anti-STAT3 activity of ISS-610 aryloxy triester phosphoramidate prodrugsAgeo Miccoli, Binar A Dhiani, Youcef Mehellou
Journal of Medicinal Chemistry|November 4, 2021
Aryloxy Pivaloyloxymethyl Prodrugs as Nucleoside Monophosphate ProdrugsAshwag S Alanazi, Ageo Miccoli, Youcef Mehellou
Chemmedchem|April 1, 2018
Niclosamide, a Drug with Many (Re)purposesHachemi Kadri, Olivia A Lambourne, Youcef Mehellou
Journal of Medicinal Chemistry|August 10, 2017
The ProTide Prodrug Technology: From the Concept to the ClinicYoucef Mehellou, Hardeep S Rattan, Jan Balzarini
Bioorganic & Medicinal Chemistry Letters|May 9, 2007
Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Christopher McGuigan, Andrea Brancale, et al.
Biochemical and Biophysical Research Communications|August 24, 2020
SPAK and OSR1 kinases bind and phosphorylate the β<sub>2</sub>-Adrenergic receptorAbdulrahman Elzwawi, Gillian Grafton, Nicholas M Barnes, et al.
Journal of Medicinal Chemistry|August 26, 2016
Nucleoside Phosphate and Phosphonate Prodrug Clinical CandidatesPeter J Thornton, Hachemi Kadri, Ageo Miccoli, et al.
Biochemical and Biophysical Research Communications|August 1, 2018
C-terminal phosphorylation of SPAK and OSR1 kinases promotes their binding and activation by the scaffolding protein MO25Youcef Mehellou, Mubarak A Alamri, Binar A Dhiani, et al.
Pageof 5